Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Brian Collette"'
Autor:
Satoshi Kashiwagi, Jianping Yuan, Benjamin Forbes, Mathew L Hibert, Eugene L Q Lee, Laura Whicher, Calum Goudie, Yuan Yang, Tao Chen, Beth Edelblute, Brian Collette, Laurel Edington, James Trussler, Jean Nezivar, Pierre Leblanc, Roderick Bronson, Kosuke Tsukada, Makoto Suematsu, Jeffrey Dover, Timothy Brauns, Jeffrey Gelfand, Mark C Poznansky
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e82899 (2013)
Safe and effective immunologic adjuvants are often essential for vaccines. However, the choice of adjuvant for licensed vaccines is limited, especially for those that are administered intradermally. We show that non-tissue damaging, near-infrared (NI
Externí odkaz:
https://doaj.org/article/b0b16a47fa6a41578fd3cab79619b31b
Autor:
Mark C. Poznansky, Glenn Dranoff, Sandra Orsulic, Michael Birrer, Fabrizio Vianello, Maria Cristina Mingari, Magdalena Kowalski, Deyin Xing, Brian Collette, Beth Edelblute, Benjamin Forbes, Rachel Ingraham, Pierre Leblanc, Michael Santosuosso, Jianping Yuan, Satoshi Kashiwagi, Elda Righi
Supplementary Materials PDF file - 126K, supplementary methods and figure legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00925dc953751392f5f1582ad00fd755
https://doi.org/10.1158/0008-5472.22388553
https://doi.org/10.1158/0008-5472.22388553
Autor:
Mark C. Poznansky, Glenn Dranoff, Sandra Orsulic, Michael Birrer, Fabrizio Vianello, Maria Cristina Mingari, Magdalena Kowalski, Deyin Xing, Brian Collette, Beth Edelblute, Benjamin Forbes, Rachel Ingraham, Pierre Leblanc, Michael Santosuosso, Jianping Yuan, Satoshi Kashiwagi, Elda Righi
PDF file - 89K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38a6341bf1285535dd34a4523804bd6e
https://doi.org/10.1158/0008-5472.22388556
https://doi.org/10.1158/0008-5472.22388556
Autor:
Alex Pellerin, Brian Collette, Abhishek Datta, Jason D. Fontenot, Liaomin Peng, Brian T. Wipke, David J. Huss, Arun K. Kannan
Publikováno v:
Immunology. 148:276-286
Interleukin-2 (IL-2) is a critical regulator of immune homeostasis through its non-redundant role in regulatory T (Treg) cell biology. There is major interest in therapeutic modulation of the IL-2 pathway to promote immune activation in the context o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fe6485b380c3eab71e3db0e2f89dfcb
https://doi.org/10.1111/imm.12609
https://doi.org/10.1111/imm.12609
Autor:
Robert H. Scannevin, Geoffrey O. Gillard, John Anderson, Jianhua Chao, David J. Huss, Jason D. Fontenot, Brian Collette
Publikováno v:
Journal of Neuroimmunology. 283:74-85
Fumarate-containing pharmaceuticals are potent therapeutic agents that influence multiple cellular pathways. Despite proven clinical efficacy, there is a significant lack of data that directly defines the molecular mechanisms of action of related, ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::309aab6e088632339370c462cabfffb3
https://doi.org/10.1016/j.jneuroim.2015.04.006
https://doi.org/10.1016/j.jneuroim.2015.04.006
Autor:
Brian Collette, Makoto Suematsu, Jeffrey S. Dover, Laurel Edington, Eugene L. Q. Lee, Jeffrey A. Gelfand, Jianping Yuan, Laura Whicher, Mathew L. Hibert, Roderick T. Bronson, Jean Nezivar, Pierre Leblanc, Kosuke Tsukada, Calum Goudie, James T. Trussler, Yuan Yang, Timothy Brauns, Beth Edelblute, Tao Chen, Benjamin Forbes, Satoshi Kashiwagi, Mark C. Poznansky
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e82899 (2013)
PLoS ONE
PLoS ONE
Safe and effective immunologic adjuvants are often essential for vaccines. However, the choice of adjuvant for licensed vaccines is limited, especially for those that are administered intradermally. We show that non-tissue damaging, near-infrared (NI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a650043349abb67a4fd501a10dbfcc7
http://europepmc.org/articles/PMC3859633?pdf=render
http://europepmc.org/articles/PMC3859633?pdf=render
Autor:
Rachel Ingraham, Pierre Leblanc, Brian Collette, Magdalena Kowalski, Maria Cristina Mingari, Michael J. Birrer, Jianping Yuan, Beth Edelblute, Satoshi Kashiwagi, Glenn Dranoff, Benjamin Forbes, Deyin Xing, Michael Santosuosso, Mark C. Poznansky, Sandra Orsulic, Fabrizio Vianello, Elda Righi
The chemokine CXCL12 and its receptor CXCR4 are expressed widely in human cancers, including ovarian cancer, in which they are associated with disease progression at the levels of tumor cell proliferation, invasion, and angiogenesis. Here, we used an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c224395071b1184405e82431ee1919f
http://hdl.handle.net/11567/390544
http://hdl.handle.net/11567/390544